arrow
T

Tsutomu Takeuchi

keio university
H指数:98
被引数:5.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predictive correlates of arthritis and joint damage in systemic lupus erythematosus: a multinational prospective cohort study

系统性红斑狼疮中关节炎和关节损伤的预测性相关因素:一项多国前瞻性队列研究

2026-05-110
OA
Circulating microRNAs associated with tumour necrosis factor or fibroblast-like synoviocytes predict cartilage damage in early rheumatoid arthritis treated with methotrexate plus adalimumab: a subanalysis of the MIRACLE study

与肿瘤坏死因子或成纤维样滑膜细胞相关的循环microRNAs可预测接受甲氨蝶呤联合阿达木单抗治疗的早期类风湿关节炎患者的软骨损伤:MIRACLE研究的亚组分析

2026-03-011
PRE
Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: Long-term efficacy and safety through 5 years in the SELECT-EARLY study

乌帕替尼单药治疗与甲氨蝶呤单药治疗在甲氨蝶呤初治的日本类风湿关节炎患者中的比较:SELECT-EARLY研究中的5年长期疗效与安全性

2026-01-010
PRE
Acceptability and Barriers to Implementation of the EULAR Recommendations for the Role of the Nurse in the Management of Chronic Inflammatory Arthritis: A Mixed-Methods Study With Nurses and Rheumatologists in Japan

接受度及实施障碍:关于EULAR关于护士在慢性炎症性关节炎管理中作用的建议——一项在日本护士和风湿病学家中进行的混合方法研究

2025-12-170
PRE
Predictors of damage accrual by organ domain in systemic lupus erythematosus

系统性红斑狼疮中按器官领域累积损伤的预测因子

2025-12-010
OAAI
Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically Active
2025-12-010
OAAI
Comparative single-cell and spatial profiling of anti-SSA-positive and anti-centromere-positive Sjögren’s disease reveals common and distinct immune activation and fibroblast-mediated inflammation

比较SSA抗体阳性和着丝点抗体阳性的舍格伦综合征的单细胞及空间分析,揭示了共同的和独特的免疫激活以及成纤维细胞介导的炎症。

2025-09-220
OAAI
Risk factors of cytomegalovirus reactivation in patients with rheumatic musculoskeletal diseases undergoing remission induction therapy with high-dose glucocorticoids; a prospective short-term cohort study

巨细胞病毒复发的危险因素:在应用大剂量糖皮质激素进行缓解诱导治疗的风湿性肌肉骨骼疾病患者中;一项前瞻性短期队列研究

2025-08-120
PRE
An update on the integrated safety analysis of filgotinib in patients with moderate to severe active rheumatoid arthritis over a median of 4.3 years

关于filgotinib在中等至重度活动性类风湿关节炎患者中的综合安全性分析的中位4.3年更新。

2025-04-280
PRE
Trans-omics landscape of systemic vasculitis identified matrix metalloproteinase 12 as a novel signature molecule

系统性血管炎的跨组学景观识别出基质金属蛋白酶12为一种新型标志分子

2025-03-260
PRE
Frequency and Determinants of Flare and Persistently Active Disease in a Large Multinational Prospective Lupus Cohort

系统性红斑狼疮大型跨国前瞻性队列中flare和持续性活动性疾病的频率与决定因素

2025-02-260
OAAI
Time trends of variability in disease activity in systemic lupus erythematosus
2025-02-120
OAAI